Literature DB >> 19754776

Measurements of hypoxia ([(18)F]-FMISO, [(18)F]-EF5) with positron emission tomography (PET) and perfusion using PET ([(15)O]-H(2)O) and power Doppler ultrasonography in feline fibrosarcomas*.

K Allemann1, M T Wyss, M Wergin, S Ohlerth, C Rohrer-Bley, S M Evans, A P Schubiger, S M Ametamey, B Kaser-Hotz.   

Abstract

Abstract The aim of this study was to evaluate if hypoxia in feline fibrosarcomas can be detected. This was done using positron emission tomography (PET), two hypoxia tracers and polarographic pO(2) measurements. Of the seven cats included, five received [(18)F]-fluoromisonidazole and two 2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide. Perfusion was evaluated with [(15)O]-H(2)O (n = 4) and with contrast-enhanced power Doppler ultrasonography (n = 5). Hypoxia was detected in three cats. Polarographic pO(2) measurements did not confirm PET results. In the ultrasonographic evaluation, low vascularity and low perfusion were seen with a peripheral vascular pattern and no perfusion in the centre of the tumour. This was in contrast to the [(15)O]-H(2)O scans, where central perfusion of the tumour was also found. In conclusion, it appears that hypoxia exists in this tumour type. The presence of tumour necrosis and heterogeneous hypoxia patterns in these tumours may explain the found discrepancies between the applied techniques.

Entities:  

Year:  2005        PMID: 19754776     DOI: 10.1111/j.1476-5810.2005.00081.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  6 in total

Review 1.  Preclinical PET tracers for the evaluation of sarcomas: understanding tumor biology.

Authors:  Ian R Sigal; Ronnie Sebro
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-12-20

2.  Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats.

Authors:  Rachel M Bartlett; Bradley J Beattie; Manoj Naryanan; Jens-Christoph Georgi; Qing Chen; Sean D Carlin; Gordon Roble; Pat B Zanzonico; Mithat Gonen; Joseph O'Donoghue; Alexander Fischer; John L Humm
Journal:  J Nucl Med       Date:  2012-08-29       Impact factor: 10.057

3.  Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma.

Authors:  Cameron J Koch; Joshua S Scheuermann; Chaitanya Divgi; Kevin D Judy; Alexander V Kachur; Richard Freifelder; Janet S Reddin; Joel Karp; James B Stubbs; Stephen M Hahn; Jason Driesbaugh; Deborah Smith; Susan Prendergast; Sydney M Evans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-29       Impact factor: 9.236

4.  Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.

Authors:  Esther G C Troost; Peter Laverman; Mariëlle E P Philippens; Jasper Lok; Albert J van der Kogel; Wim J G Oyen; Otto C Boerman; Johannes H A M Kaanders; Johan Bussink
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-18       Impact factor: 9.236

Review 5.  Current molecular imaging positron emitting radiotracers in oncology.

Authors:  Aizhi Zhu; Hyunsuk Shim
Journal:  Nucl Med Mol Imaging       Date:  2011-02-01

Review 6.  Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma.

Authors:  Walaa Hamed Shaker Nasry; Chelsea K Martin
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.